Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian P Halliday

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of the American Heart Association|September 11, 2025
Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic CardiomyopathyDaniel J Hammersley, Hassan A Zaidi, Richard E Jones, et al.
European Journal of Heart Failure|September 20, 2023
Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathyDaniel J Hammersley, Richard E Jones, Ruth Owen, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
European Journal of Heart Failure|September 13, 2023
Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery diseaseRichard E Jones, Daniel J Hammersley, Sean Zheng, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Circulation. Genomic and Precision Medicine|November 28, 2023
Genotype-Phenotype Taxonomy of Hypertrophic CardiomyopathyLara Curran, Antonio de Marvao, Paolo Inglese, et al.
Journal of the American College of Cardiology|September 10, 2021
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic CardiomyopathyAntonio de Marvao, Kathryn A McGurk, Sean L Zheng, et al.
Nature Cardiovascular Research|April 26, 2024
Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery diseaseRichard E Jones, Anja V Gruszczyk, Christina Schmidt, et al.
Journal of the American College of Cardiology|June 2, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataUpasana Tayal, Job A J Verdonschot, Mark R Hazebroek, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of the American Heart Association|September 11, 2025
Fibrosis Entropy Is Associated With Life-Threatening Arrhythmia in Nonischemic CardiomyopathyDaniel J Hammersley, Hassan A Zaidi, Richard E Jones, et al.
European Journal of Heart Failure|September 20, 2023
Phenotype, outcomes and natural history of early-stage non-ischaemic cardiomyopathyDaniel J Hammersley, Richard E Jones, Ruth Owen, et al.
Circulation|March 30, 2017
Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic DysfunctionBrian P Halliday, Ankur Gulati, Aamir Ali, et al.
European Journal of Heart Failure|September 13, 2023
Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery diseaseRichard E Jones, Daniel J Hammersley, Sean Zheng, et al.
Lancet (London, England)|November 16, 2018
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trialBrian P Halliday, Rebecca Wassall, Amrit S Lota, et al.
Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.
Circulation. Genomic and Precision Medicine|November 28, 2023
Genotype-Phenotype Taxonomy of Hypertrophic CardiomyopathyLara Curran, Antonio de Marvao, Paolo Inglese, et al.
Journal of the American College of Cardiology|September 10, 2021
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic CardiomyopathyAntonio de Marvao, Kathryn A McGurk, Sean L Zheng, et al.
Nature Cardiovascular Research|April 26, 2024
Assessment of left ventricular tissue mitochondrial bioenergetics in patients with stable coronary artery diseaseRichard E Jones, Anja V Gruszczyk, Christina Schmidt, et al.
Journal of the American College of Cardiology|June 2, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional DataUpasana Tayal, Job A J Verdonschot, Mark R Hazebroek, et al.
Pageof 9